The limited clinical utility of a routine creatine kinase (CK) on admission to a psychiatric inpatient unit
2024

The Limited Usefulness of Routine Creatine Kinase Testing in Psychiatric Patients

Sample size: 2358 publication 10 minutes Evidence: low

Author Information

Author(s): Scott Fraser, Matt Butler, Jonathan P. Rogers

Primary Institution: South London and Maudsley NHS Foundation Trust

Hypothesis

Routine testing of creatine kinase (CK) on admission to psychiatric inpatient units may have limited clinical utility.

Conclusion

Routine screening for creatine kinase in psychiatric inpatients does not effectively identify neuroleptic malignant syndrome and has minimal impact on clinical management.

Supporting Evidence

  • Only 14 patients received a new diagnosis after abnormal CK results, indicating low diagnostic yield.
  • No cases of neuroleptic malignant syndrome were identified in the study.
  • Routine CK testing had minimal impact on clinical management, with most changes being minor adjustments.

Takeaway

Doctors checked a blood test called creatine kinase for many patients in a mental hospital, but it didn't help them find serious problems or change how they treated the patients.

Methodology

A descriptive retrospective cohort study was conducted using an electronic case register to analyze psychiatric inpatient admissions over four years.

Potential Biases

Potential bias due to reliance on electronic records and the possibility of unrecorded interventions.

Limitations

The study relied on the accuracy of clinical records and was limited to one mental health trust, which may affect generalizability.

Participant Demographics

{"age":{"mean":40.7,"standard_deviation":15.7},"sex_distribution":{"male":49.4,"female":50.6}}

Digital Object Identifier (DOI)

10.1186/s12888-024-06386-8

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication